ABOS Financials

Acumen Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$1.86

Market Cap

$114.48M

EPS

$-2.21

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-102.33M

EPS (Diluted)

$-1.71

Balance Sheet Highlights

Total Assets

$238.99M

Total Liabilities

$57.18M

Shareholders Equity

Cash & Equivalents

$35.63M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-86.22M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

-36148.3%

ROE

-0.9%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ABOS revenue?

View ABOS's income statement for detailed revenue data.

Is ABOS profitable?

ABOS reported a loss of $102.33M in the most recent quarter.

What is ABOS market cap?

ABOS has a market capitalization of $114.48M, making it a small-cap stock.

Does ABOS have debt?

View ABOS's balance sheet for debt information.

What is ABOS cash flow?

Cash flow data is available in the full financial statements.